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In 2010, the European surveillance network for travel-
associated Legionnaires’ disease (ELDSNet, previously 
EWGLINET) received reports of 864 cases of travel-
associated Legionnaires’ disease, of whom 24 were 
reported to have had a fatal outcome. As in previous 
years, a very low proportion of clinical isolates were 
obtained (45 cases, 5.6%). In the 2010 dataset, male 
cases outnumbered female cases by 2.6:1 and had 
a median age of 61 years (range: 21–96), while the 
median age for women was 63 years (range: 12–95). 
The network identified 100 new clusters in 2010, of 
which 44 involved only one case from each reporting 
country and would probably not have been detected 
by national surveillance schemes alone. The largest 
cluster (having 14 cases) was associated with a cruise 
ship. Legionella species were detected at 61 of the 100 
accommodation site clusters investigated. The names 
of five accommodation sites were published on the 
ECDC website.
Introduction
Legionnaires’ disease is an uncommon form of pneu-
monia caused by Legionella bacteria. It has no par-
ticular clinical features that clearly distinguish it from 
other types of pneumonia, and laboratory investiga-
tions must be carried out to confirm the diagnosis. 
It normally takes between 2 and 10 days to develop 
symptoms (typically five to six days) but very rarely, 
some cases may take two to three weeks to develop 
symptoms. Patients usually start with a dry cough, 
fever, headache and sometimes diarrhoea and many go 
on to get pneumonia. People over the age of 50 years 
are more at risk than younger people, and males are 
more at risk than females. Effective antibiotic treat-
ment is available if the diagnosis is made early in the 
illness. Death due to the disease occurs in about 5% to 
15% of travellers who develop the disease, depending 
on their age and health status. Smokers are more at 
risk than non-smokers [1].
In April 2010, ELDSNet (European Legionnaires’ 
Disease Surveillance Network) was established, when 
the European surveillance scheme for travel-associ-
ated Legionnaires’ disease (EWGLINET) was trans-
ferred to the European Centre for Disease Prevention 
Box
European Union case definition of Legionnaires’ disease 
Clinical criteria: 
Any person with pneumonia.
Laboratory criteria for case confirmation:
At least one of the following three:
•	 Isolation	of	Legionella spp. from respiratory secretions or 
any normally sterile site; 
•	 Detection	of	Legionella pneumophila antigen in urine; 
•	 Legionella pneumophila serogroup 1 specific antibody 
response.
Laboratory criteria for a probable case:
At least one of the following four:
•	 Detection	of	Legionella pneumophila antigen in respiratory 
secretions	or	lung	tissue,	e.g.	by	DFA	staining	using	
monoclonal-antibody derived reagents; 
•	 Detection	of	Legionella spp. nucleic acid in a clinical 
specimen; 
•	 Legionella pneumophila non-serogroup 1 or other 
Legionella spp. specific antibody response; 
•	 L. pneumophila serogroup 1, other serogroups or other 
Legionella species: single high titre in specific serum 
antibody.
Epidemiological criteria:








positive laboratory test for a probable case OR an 
epidemiological link. 
Confirmed case 




Individual cases of travel-associated Legionnaire
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and Control (ECDC) from the former coordinating cen-
tre in London. EWGLINET was established in 1987 by 
the European Working Group for Legionella Infections, 
making ELDSNet/EWGLINET the oldest European infec-
tious disease surveillance network. The added value of 
European surveillance has been clearly demonstrated 
since the late 80s [2-5]. The objectives of this article 
are to communicate the results of the surveillance of 
travel-associated Legionnaires’ disease in European 
Union (EU)/European Economic Area (EEA) Member 
States for cases with onset of disease in 2010. 
Methods
Legionnaires’ disease is a statutorily notifiable disease 
in all EU/EEA Member States. The EU case definition [2] 
is shown (Box).  
Individual cases of travel-associated Legionnaires’ 
disease are in most circumstances diagnosed and 
reported by the case’s country of residence to the 
European Surveillance System (TESSy) at ECDC. Case 
reports include age, sex, date of onset of disease, 
method of diagnosis and travel information for the dif-
ferent places where the case had stayed within two to 
ten days before onset of disease. After receiving the 
report, the TESSy database is searched to determine 
whether a new case should be classified as a single 
case or as part of a cluster, according to the following 
definitions used by the network.
A single case: a person who stayed at a public accom-
modation site in the two to ten days before onset of 
illness and the site has not been associated with any 
other case of Legionnaires’ disease in the previous two 
years. 
•	 A cluster: two or more cases who stayed at the same 
public accommodation site in the two to ten days 
before onset of illness and whose onsets were 
within the same two-year period. 
•	 If there are three or cases or more with onset of dis-
ease within the same three-month period, this is 
called a rapidly evolving cluster and a notification 
is sent to all tour operators. 
If there is a single case, a notification is sent to the 
country where the accommodation site is situated, with 
a copy to the reporting country. If the case is a part 
of a cluster, a notification is sent to all network mem-
bers. When the accommodation site is outside EU and 
when a specific contact person for ELDSNet is known, 
the country concerned is included as a recipient of the 
notification. All notifications, except those relating to 
Figure 1
Annual number of reported cases of travel-associated Legionnaires’ disease, EU/EEA countries, 1987–2010
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domestic travellers, are also sent to the World Health 
Organization. 
When a cluster is detected, a full investigation is 
required at the accommodation site and preliminary 
results from the risk assessment and start of control 
measures should be reported back to ECDC within two 
weeks of the alert, using the standard operating pro-
cedures Form A [5]. The investigation is carried out by 
regional or local public health authority, depending on 
the national rules in each country. The investigation 
and risk assessment carried out are described in the 
EWGLI technical guidelines for the investigation, control 
and prevention of travel associated Legionnaires’ dis-
ease [4].
A second form, Form B, is then used to report the results 
of environmental sampling and the control measures 
applied at the site back to the coordinating centre in 
ECDC within a further four weeks, thus allowing six 
weeks in total for all investigations to be completed. 
If the forms are not returned within the time frames, 
or they report that actions and control measures are 
unsatisfactory, ELDSNet publishes the details of the 
site associated with the cluster on its website and tour 
operators are informed about the accommodation site 
being published. Information is removed from the web-
site when the investigations and control measures are 
reported to have been satisfactorily completed. If a 
cluster is associated with more than one accommoda-
tion site, it is noted as a ‘complex cluster’ and all sites 
stayed at by the cluster cases are subject to the same 
investigation procedures as described above.
The data presented here is also included in the annual 
surveillance report for Legionnaires’ disease 2010 [5]. 
In 2010, there were no data from Germany, but they are 
now part of the travel-associated Legionnaires’ dis-
ease reporting scheme. 
We use in this article a similar reporting format as 
used in previous publications on travel-associated 
Legionnaires’ disease data, to facilitate comparison 
[6-9]. 
Results
A total of 864 cases of travel-associated Legionnaires’ 
disease with onset of disease in 2010 were reported to 
EWGLINET/ELDSNet. This is an increase (+5.6%) com-
pared with the 818 cases reported in 2009 [10], but 
does not reach the peak of 947 cases observed in 2007 
(Figure 1). 
Cases were reported from 19 EU/EEA countries (United 
Kingdom (UK) counted as one country) and two coun-
tries outside the EU (United States, 11 cases, and 
Croatia, 2 cases), as the cases were associated with 
accommodation sites in the EU. The countries that 
reported the most cases were France (n= 191), the UK 
(n=154), the Netherlands (n=148) and Italy (n=142) 
(Table). 
 Among the reported cases, 624 (72.2%) were male and 
240 (27.7%) were female, resulting in a male to female 
ratio of 2.6:1, which was almost identical to the ratio 
for 2009 (2.7:1) [10].
Cases were reported in all age groups except the 
youngest one, the median age being 61 years (range: 
21–96) in male cases and 63 years (range: 12–95) in 
female cases. The highest proportion of cases was in 
the 60–69-year age group (male cases: n=183; female 
cases: n=82). 
Outcome of illness was reported for 514 (59.5%) cases 
(voluntary reporting and different definitions are used 
in the reporting countries). Of these cases, 24 (4.7%) 
Table 
Cases of travel-associated cases of Legionnaires’ disease by 
reporting country, 2009–10
Reporting country
Number of reported cases
2009 2010 
France 163 191









United States 11 11
Finland 6 8
Ireland 2 7











Source of 2009 data: The European Surveillance System (TESSy) 
data downloaded 5 August 2011.
4 www.eurosurveillance.org
were reported to have had a fatal outcome, almost the 
same proportion reported in 2009. Of the four female 
cases who had a fatal outcome, one was aged 58 years 
and the other three were aged 82 years. The fatal cases 
among the 20 male cases were aged from 38 years up 
to 90 years-old; the majority of male cases with a fatal 
outcome were in the age group 60–69 years.
There is seasonal variation in the onset of travel-asso-
ciated Legionnaires’ disease: with more cases appear-
ing during late summer [6-9]. In 2010, the number of 
cases peaked in August, with 156 cases, followed by 
September, with 136 cases. January, February, March, 
April and December were the months when the lowest 
number of cases, approximately 30 per month, had 
onset of disease.
Microbiological analysis
A total of 809 (94%) cases in 2010 were reported as 
confirmed, according to the EU case definition. Of 
these, 45 (6%) were diagnosed by culture of the causa-
tive organism, a decrease from 10% in 2009. Of the 
culture-confirmed cases, 27 were also diagnosed by 
urinary antigen detection. The vast majority of con-
firmed cases (n=762, 94%) were diagnosed by detec-
tion of urinary antigen alone. A total of 10 cases (1%) 
were confirmed as being due to Legionella pneumoph-
ila serogroup 1 by specific antibody response. 
The remaining 55 (6%) cases were classified as prob-
able following presumptive diagnosis by single high 
titre (n=28, 3%), detection of Legionella spp. nucleic 
acid (n=19, 2%) and antibody response specific for 
L. pneumophila non-serogroup 1 or other Legionella 
Figure 2
Accommodation sites per destination country associated with cases of travel-associated Legionnaires’ disease, EU Member 
States and neighbouring countries, 2010



















spp. (n=8, 1.0%). Altogether, 672 (78%) cases were 
reported as being infected with L. pneumophila sero-
group 1, three with L. pneumophila serogroup 3, two 
with L. pneumophila serogroup 6, one with L. pneu-
mophila serogroup 12 and three with L. pneumoph-
ila mixed serogroups. Furthermore, 158 cases were 
reported as L. pneumophila serogroup unknown, 1 as 
Legionella bozemannii and 10 as Legionella species 
unknown. For 14 cases, the Legionella species was not 
reported. Sequence-based types were reported for 13 
cases (eight from Denmark, four from the UK and one 
from Austria).
Travel
The 864 reported cases had made 1,279 visits to 
accommodation sites around the world. 
They visited a total of 66 countries in the 2–10 days 
before onset of disease. A total of 654 (76%) cases trav-
elled within the EU: 621 cases visited only one Member 
State and 33 more than one. Some 20% (n=175) of 
cases travelled outside the EU: 166 to a single destina-
tion and 9 to more than one non-EU country. A total of 
30 cases (3%) went to both EU and non-EU destinations 
and 32 cases were associated with cruise ships.
 Italy was the country where most cases (n=209) were 
infected, followed by Spain (177 cases), France (172 
cases) and Turkey (48 cases). A total of 169 cases 
were French residents: 105 (62%) of them visited 
accommodation sites in France. Likewise, of the 119 
Italian residents reported with Legionnaires’ disease, 
105 (88%) had visited accommodation sites in Italy. 
The number of accommodation sites per destination 
country with cases of travel-associated Legionnaires’ 
disease is shown in Figures 2 and 3.
Clusters 
A total of 100 new clusters (74 in EU Member States 
and 26 outside the EU) were detected in 2010, involv-
ing 213 associated cases. The largest cluster was 
associated with a cruise ship and involved 14 associ-
ated cases. Italy had the highest number of clusters 
(n=24) followed by Spain (n=14), France (n=12) and 
Turkey (n=10). Altogether, clusters in the EU occurred 
in 13 Member States and on two cruise ships. Outside 
the EU, 26 clusters occurred in 16 countries and on one 
cruise ship.
Of the 100 clusters, 44 comprised single cases reported 
from two or more countries and would probably not 
have been detected without the European surveillance 
network. More than 50% of the clusters (n=51) were 
detected between July and September.
Complex clusters were more associated with accom-
modation sites in countries where organised tours to 
Figure 3










several tourist sites took place, such as China, India, 
South Africa and Thailand.
Six rapidly evolving clusters were detected: Greece 
(n=2), Italy (n=2), Spain (n=1) and on a cruise ship 
(n=1).
The number of clusters per destination country is 
shown in Figures 4 and 5.
Investigations and publication
All accommodation sites associated with a cluster 
of travel-associated Legionnaires’ disease ,situated 
within an EU Member State, should be investigated as 
described above. In 2010, 100 form Bs were returned to 
EWGLINET/ELDSNet, reporting detection of Legionella 
in 61 accommodation sites. The forms were returned 
not only by Member States but also by several non-EU 
countries, on a voluntary basis. However, for five sites, 
form B was not received or the form stated uncertainty 
regarding the control measures taken, so the names 
and locations of these sites were published on the 
ECDC website. 
Discussion
During 2006 to 2008, the number of cases of travel-
associated Legionnaires’ disease reported per year 
had varied from 866 to 947 [7-9]. Legionnaires’ dis-
ease is still underascertained in most European coun-
tries since specific testing for Legionella in patients 
with pneumonia is not a routine procedure [10]. 
Furthermore, use of urinary antigen detection as the 
only laboratory method will lead to underdetection of 
cases with Legionella non-pneumophila and non-sero-
group 1, since the method is designed to detect only 
L. pneumophila serogroup 1. It is estimated that only 
Figure 4
Clusters of cases of travel-associated Legionnaires’ disease per destination country in EU Member States and neighbouring 
countries, 2010


















10% of all cases of Legionnaires‘ disease are notified 
to public health authorities [10].
For several years, the four countries reporting the vast 
majority of travel-associated cases have been France, 
the UK, Italy and the Netherlands. This indicates high 
awareness of Legionnaires’ disease among clinicians 
in these countries. France and Italy also reported the 
highest numbers of cases in domestic travellers. 
The proportion of cases diagnosed by culture 
decreased from 10% in 2009 to 5.6% in 2010. However, 
the decrease was not so drastic when compared with 
the number of culture-confirmed cases from 2005 to 
2008, when the proportion varied from 4.9% to 8.2% 
[6-9)]. Nevertheless, clinicians should be encouraged 
to collect more specimens for culturing. It is important 
to be able to compare clinical isolates with environ-
mental isolates from different sampling sites, to iden-
tify the source of infection and prevent any subsequent 
cases. 
The case fatality rate for 2010 (4.7%) was lower than 
the 5.8–9.8% between 2006 and 2009. However, in 
more than 40% of the cases, the clinical outcome of 
the patient was unknown at the time of reporting. In 
the interest of timely reporting and implementation of 
control measures as soon as possible at the associated 
accommodation sites, this incompleteness of outcome 
data seems acceptable. 
The added value of ELDSNet is easier to quantify than 
for other similar European surveillance networks, in 
that 44% of the clusters reported would most prob-
ably not have been detected without ELDSNet. Some 
countries do take action when a single case is reported 
to be associated with an accommodation site in that 
country, but in most countries, action is only taken 
after a cluster notification. Therefore, ELDSNet clus-
ter notifications help to identify accommodation sites 
that might pose a risk to human health while the con-
trol measures implemented prevent further cases of 
Legionnaires’ disease. This is demonstrated by the fact 
that in 61 of the 100 accommodation sites reported to 
have been sampled, Legionella bacteria were identified 
in the water systems.
Despite the challenges and changes in reporting sys-
tems with transition of the network to a new coordi-
nation centre in April 2010, network members have 
continued to report cases in a timely manner and 
undertake cluster management in response to notifica-
tions. This highlights the dedication and considerable 
added value of this network for public health in Europe.
Figure 5
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